These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28534113)

  • 1. Cysteine-rich low molecular weight antimicrobial peptides from Brevibacillus and related genera for biotechnological applications.
    Baindara P; Kapoor A; Korpole S; Grover V
    World J Microbiol Biotechnol; 2017 Jun; 33(6):124. PubMed ID: 28534113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intramolecular disulfide-stapled structure of laterosporulin, a class IId bacteriocin, conceals a human defensin-like structural module.
    Singh PK; Solanki V; Sharma S; Thakur KG; Krishnan B; Korpole S
    FEBS J; 2015 Jan; 282(2):203-14. PubMed ID: 25345978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens.
    Baindara P; Singh N; Ranjan M; Nallabelli N; Chaudhry V; Pathania GL; Sharma N; Kumar A; Patil PB; Korpole S
    Microbiology (Reading); 2016 Aug; 162(8):1286-1299. PubMed ID: 27267959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications.
    Papagianni M
    Biotechnol Adv; 2003 Sep; 21(6):465-99. PubMed ID: 14499150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics.
    Sang Y; Blecha F
    Anim Health Res Rev; 2008 Dec; 9(2):227-35. PubMed ID: 18983725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.
    Singh PK; Chittpurna ; Ashish ; Sharma V; Patil PB; Korpole S
    PLoS One; 2012; 7(3):e31498. PubMed ID: 22403615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug.
    Khurshid Z; Zafar MS; Naseem M; Khan RS; Najeeb S
    Curr Pharm Des; 2018; 24(10):1130-1137. PubMed ID: 29611481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.
    Yang X; Yousef AE
    World J Microbiol Biotechnol; 2018 Mar; 34(4):57. PubMed ID: 29594558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antimicrobial peptides: defensins, cathelicidins and histatins.
    De Smet K; Contreras R
    Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
    Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes.
    Schmitt P; Rosa RD; Destoumieux-Garzón D
    Biochim Biophys Acta; 2016 May; 1858(5):958-70. PubMed ID: 26498397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
    Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
    Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide Bridges in Defensins.
    Zhao BC; Lin HC; Yang D; Ye X; Li ZG
    Curr Top Med Chem; 2015; 16(2):206-19. PubMed ID: 26126908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.
    Falanga A; Nigro E; De Biasi MG; Daniele A; Morelli G; Galdiero S; Scudiero O
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28726740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana.
    Zhao H; Kong Y; Wang H; Yan T; Feng F; Bian J; Yang Y; Yu H
    J Pept Sci; 2011 Jul; 17(7):540-4. PubMed ID: 21538709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defensins as a promising class of tick antimicrobial peptides: a scoping review.
    Wu J; Zhou X; Chen Q; Chen Z; Zhang J; Yang L; Sun Y; Wang G; Dai J; Feng T
    Infect Dis Poverty; 2022 Jun; 11(1):71. PubMed ID: 35725522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Defensin-Like Peptide Associated with Two Other New Cationic Antimicrobial Peptides in Transcriptome of the Iranian Scorpion Venom.
    Baradaran M; Jalali A; Naderi Soorki M; Galehdari H
    Iran Biomed J; 2017 May; 21(3):190-6. PubMed ID: 27794585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of Antimicrobial Peptides in Vertebrates.
    Avila EE
    Curr Protein Pept Sci; 2017; 18(11):1098-1119. PubMed ID: 27526932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insect defensin-derived β-hairpin peptide with enhanced antibacterial activity.
    Gao B; Zhu S
    ACS Chem Biol; 2014 Feb; 9(2):405-13. PubMed ID: 24228718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.